Mural Oncology Plc (MURA)
$3.5
+0.04
(+1.16%)▲
Market is closed - opens 7 PM, 29 Jul 2024
Performance
- $3.44$3.54$3.50
1.71%
Downside
Day's Volatility :2.82%
Upside
1.13%
- $2.88$17.00$3.50
17.71%
Downside
52 Weeks Volatility :83.06%
Upside
79.41%
Returns
| Period | Mural Oncology Plc | Index (Russel 2000) |
|---|---|---|
3 Months | -3.35% | 0.0% |
6 Months | -26.54% | 0.0% |
1 Year | -8.95% | 0.0% |
3 Years | -8.95% | -20.2% |
Highlights
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | 0.0% |
Return On Equity TTM | 0.0% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
Diluted Eps TTM | 0.0 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
Analyst Recommendation
Buy
85%Buy
14%Hold
0
0%Sell
Based on 7 Wall street analysts offering stock ratings for Mural Oncology Plc(by analysts ranked 0 to 5 stars)
Technicals Summary
Sell
Neutral
Buy
Mural Oncology Plc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Mural Oncology Plc | 12.7% | -26.54% | -8.95% | -8.95% | -8.95% |
 Moderna, Inc. | -1.67% | 18.26% | -0.21% | -64.15% | 752.69% |
 Regeneron Pharmaceuticals, Inc. | -0.46% | 13.21% | 45.59% | 84.19% | 244.2% |
 Novo Nordisk A/s | -11.0% | 18.31% | 61.56% | 186.46% | 423.59% |
 Vertex Pharmaceuticals Incorporated | 3.85% | 14.43% | 39.88% | 147.45% | 195.07% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Mural Oncology Plc | NA | NA | NA | 0.0 | 0.0 | 0.0 | NA | NA |
Moderna, Inc. | 24.73 | NA | 0.0 | -7.19 | -0.38 | -0.16 | NA | 33.47 |
Regeneron Pharmaceuticals, Inc. | 31.35 | 31.35 | 1.46 | 44.44 | 0.15 | 0.08 | NA | 250.15 |
Novo Nordisk A/s | 44.28 | 44.28 | 2.36 | 3.43 | 1.0 | 0.25 | 0.01 | 22.18 |
Vertex Pharmaceuticals Incorporated | 31.85 | 31.85 | 0.53 | 16.98 | 0.24 | 0.13 | NA | 71.8 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Mural Oncology Plc | Buy | $58.0M | -8.95% | NA | 0.0% |
Moderna, Inc. | Buy | $45.3B | 752.69% | 24.73 | -115.82% |
Regeneron Pharmaceuticals, Inc. | Buy | $116.9B | 244.2% | 31.35 | 29.45% |
Novo Nordisk A/s | Buy | $572.0B | 423.59% | 44.28 | 36.55% |
Vertex Pharmaceuticals Incorporated | Buy | $126.7B | 195.07% | 31.85 | 39.46% |
Company Information
Organization | Mural Oncology Plc |
Employees | 119 |
CEO | Ms. Caroline J. Loew Ph.D. |
Industry | Miscellaneous |
Discover More
A Spac I Acquisition Corp
$3.50
+1.16%
Keyarch Acquisition Corp
$3.50
+1.16%
Connexa Sports Technologies Inc
$3.50
+1.16%
Us Value Etf
$3.50
+1.16%
First Wave Biopharma Inc
$3.50
+1.16%
Global X Msci Next Emerging
$3.50
+1.16%
Fat Projects Acquisition Corp
$3.50
+1.16%
Capital Link Global Fintech
$3.50
+1.16%
Applied Uv Inc
$3.50
+1.16%